SCHEMBL1068428

SCHEMBL1068428

CCCCCCCCCCCCC(OC(CCCCCCCCCCCC)C(O)CO)C(O)CO

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.52
LMNA P02545 2/20 0.52
SPHK1 Q9NYA1 2/20 0.52
GMNN O75496 1/20 0.52
POLB P06746 1/20 0.52
THPO P40225 1/20 0.52
MTOR P42345 1/20 0.52
BLM P54132 1/20 0.52
KDM4E B2RXH2 1/20 0.52
TP53 P04637 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAPT P10636 1/20 0.52
CETP P11597 1/20 0.52
HTT P42858 1/20 0.52
UBE2N P61088 1/20 0.52
PTPN1 P18031 1/20 0.47
USP2 O75604 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL940984 1.00 CYP2D6 (0.52) CYP2D6LMNASPHK1GMNNPOLB
SCHEMBL1499941 1.00 CYP2D6 (0.52) CYP2D6LMNASPHK1GMNNPOLB
SCHEMBL93582 1.00 CYP2D6 (0.52) CYP2D6LMNASPHK1GMNNPOLB
SCHEMBL4105974 1.00 CYP2D6 (0.52) CYP2D6LMNASPHK1GMNNPOLB
SCHEMBL2015033 1.00 CYP2D6 (0.52) CYP2D6LMNASPHK1GMNNPOLB
SCHEMBL1064522 1.00 CYP2D6 (0.52) CYP2D6LMNASPHK1GMNNPOLB
SCHEMBL8502257 1.00 CYP2D6 (0.52) CYP2D6LMNASPHK1GMNNPOLB
SCHEMBL9070449 1.00 CYP2D6 (0.52) CYP2D6LMNASPHK1GMNNPOLB
SCHEMBL2305353 0.98 LMNA (0.48) CYP2D6LMNASPHK1GMNNPOLB
SCHEMBL9167639 0.93 CYP2D6 (0.46) CYP2D6LMNASPHK1GMNNPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4376798-A1 PRESERVATIVES FOR COSMETIC AND PHARMACEUTICAL COMPOSITIONS Sachem, Inc. (US) 2024-06-05 EP claimed
WO-2023009849-A1 PRESERVATIVES FOR COSMETIC AND PHARMACEUTICAL COMPOSITIONS SACHEM, INC. (US) 2023-02-02 WO claimed
WO-2020186979-A1 PROTECTIVE TOOL, STERILISING AND DISINFECTING COMPOSITE SHEET MATERIAL, AND MANUFACTURING METHOD THEREFOR 深圳市康风环境科技发展有限公司 2020-09-24 WO claimed
CN-103445975-B Emulsification cosmetic composition 花王株式会社 2017-08-22 CN claimed
US-20040208783-A1 Process for the chemical and thermal disinfection AIR LIQUIDE SANTE (INTERNATIONAL ) (FR) 2004-10-21 US claimed
EP-1468606-A1 Process for the chemical and thermal disinfection Air Liquide Santé (International) (FR) 2004-10-20 EP claimed
EP-0547727-B1 Skin and hands composition containing disinfectants and antiseptics SCHUELKE & MAYR GMBH (DE) 1996-03-13 EP claimed
JP-9295994-A None JP disclosed
US-20250090435-A1 PRESERVATIVES FOR COSMETIC AND PHARMACEUTICAL COMPOSITIONS SACHEM, INC. (US) 2025-03-20 US disclosed
CN-114432169-A Multi-layer detergent composition and method of use thereof 花王株式会社 2022-05-06 CN disclosed
US-20220110906-A1 ANTIMICROBIAL DENTAL APPLIANCE 3M INNOVATIVE PROPERTIES COMPANY 2022-04-14 US disclosed
EP-3003718-B1 SUCCESSIVELY PEELABLE COEXTRUDED POLYMER FILM WITH EMBEDDED ANTIMICROBIAL LAYER(S) 3M INNOVATIVE PROPERTIES CO (US) 2021-12-29 EP disclosed
EP-3905985-A1 ANTIMICROBIAL DENTAL APPLIANCE 3M Innovative Properties Company (US) 2021-11-10 EP disclosed
US-20050053593-A1 Antimicrobial compositions and methods 3M INNOVATIVE PROPERTIES COMPANY 2005-03-10 US disclosed
US-5705182-A BACTERICIDES ADDED TO TAMPONS MCNEIL-PPC, INC. (US) 1998-01-06 US disclosed
JP-H09295994-A PRODUCTION OF GLYCOSIDE COMPOUND LION CORP 1997-11-18 JP disclosed
US-5679369-A MONO- AND DIESTERS OF POLYHYDRIC ALIPHATIC ALCOHOL AND A FATTY ACID; PREVENTION OF TOXIC SHOCK SYNDROME MCNEIL-PPC, INC. (US) 1997-10-21 US disclosed
US-5641503-A Additives to tampons MCNEIL-PPC, INC. (US) 1997-06-24 US disclosed
US-4098713-A Detergent compositions THE PROCTER & GAMBLE COMPANY (US) 1978-07-04 US disclosed
US-4025353-A CELLULOSE AND A NITROGEN-FREE NONIONIC SURFACTANT HAVING OXYALKYLENE GROUPS BEROL KEMI AB (SW) 1977-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250090435-A1 PRESERVATIVES FOR COSMETIC AND PHARMACEUTICAL COMPOSITIONS PLOD2, CUTA, PHOSPHO1 CYP2D6 1132/4885LMNA 577/4885SPHK1 683/4885
US-20220110906-A1 ANTIMICROBIAL DENTAL APPLIANCE MGLL, LIPA, MLEC CYP2D6 4424/4885LMNA 3370/4885SPHK1 3375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.